
Taiwan Business in Brief – October 2018
AstraZeneca Plans Major Investments Observing the 70th anniversary of its presence in Taiwan, pharmaceutical giant AstraZeneca announced plans to invest an additional NT$1 billion (over US$32 million) here in the next three years. AstraZeneca Taiwan president Simon Manners said the company will launch 10 new medicines by 2021, three of which have received priority approval…